Daniela Fodor, Laura Poanta, Delia Jeican. abstract CASE REPORT
|
|
- Conrad Flowers
- 5 years ago
- Views:
Transcription
1 CASE REPORTS HYPERHOMOCYSTEINEMIA AND TYPE II PROTEIN S DEFICIENCY - CAUSES OF MULTIPLE ARTERIAL THROMBOSIS Daniela Fodor, Laura Poanta, Delia Jeican REZUMAT Hiperhomocisteinemia este recunoscut\ ca un factor de risc independent pentru ateroscleroz\, dar sunt pu]ine date n literatur\ privind rolul acesteia n trombozele arteriale acute, f\r\ leziuni vasculare preexistente. Prezent\m cazul unei femei de 48 de ani cu antecedente de infarct intestino-mezenteric [i rezec]ie intestinal\. Pe parcursul spitaliz\rii aceasta a prezentat trei episoade de ischemie acut\: dou\ la nivelul intestinului sub]ire (rezolvate chirugical) [i o tromboz\ acut\ a arterei poplitee drepte (tratament conservator). Nu s-au decelat surse emboligene, nici leziuni aterosclerotice. Determin\rile de laborator au stabilit prezen]a hiperhomocisteinemiei [i a tipului II de deficit de protein\ S. Subliniem importan]a determin\rii homocisteinei serice [i a altor factori de risc pentru trombozele arteriale la un pacient cu status trombofilic, mai ales dac\ acesta este t n\r sau trombozele sunt cu localiz\ri neobi[nuite. Cuvinte cheie: hiperhomocisteinemie, deficit proteina S tip II, tromboze arteriale multiple abstract Hyperhomocysteinemia is considered to be an independent risk factor for atherosclerosis, but there is few data regarding its role in acute arterial thrombosis without any previous lesions. We present the case of a 48 years old female with personal history of small bowel infarction and intestinal resection. During the hospitalization she had three acute ischemic episodes: two at small bowel level (surgical resection), and an acute occlusion of the right popliteal artery (medical treatment). There was no embolic source and no atherosclerotic lesions. Laboratory findings showed hyperhomocysteinemia and type II protein S deficiency. We underline the importance of measuring homocysteinemia and other risk factors for arterial thrombosis in a patient with thrombophilic state, especially in a young patient or in thrombosis in unusual place. Key Words: hyperhomocysteinemia, type II protein S deficiency, multiple arterial thrombosis INTRODUCTION Even if the knowledge about the etiology of acquired or inherited thrombotic disorders have evolved a lot in the past years, mainly by elucidating the molecular mechanisms involved in the coagulation and fibrinolysis processes, the Virchow triade, postulated over 150 years ago, regarding the risk factors for thrombotic disorders (abnormalities of the blood flow, blood constituents and the vessel wall) is still valid. Today the investigation of a patient with 2 nd Internal Medicine Clinic, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania Correspondence to: Daniela Fodor, 2 nd Internal Medicine Clinic, 4 Clinicilor Str., Cluj Napoca, Romania dfodor@umfcluj.ro Received for publication: 02 Nov Revised: 23 Mar single or recurrent episodes of unique or multiple thromboses implies a thorough search of acquired or inherited thrombogenous risk factors. The common coagulation tests are not sufficient anymore in order to explain a thrombotic syndrome. We present the case of a 48 years old female with inherited thrombophilia (hyperhomocysteinemia and type II protein S deficiency) which evolved with multiple arterial thromboses. CASE REPORT M.A., 48 years old, no births in the personal history, was admitted in our hospital because of a two month history of upper abdominal pain, persistent or intermittent, sometimes colicky, not connected with food intake or time of the day, nausea, liquid vomiting or with partial digested food particles, passage of flatus, constipation and weight loss (five kilograms in two months). Daniela Fodor et al 43
2 Past medical history: a year before this admittance she had the symptoms of an acute surgical abdomen which proved to be bowel infarction and she underwent surgery with the resection of 45 centimeters of the small intestine. The histopathology exam: infarction of the entire resected segment and multiple thrombi in the small mesenteric vessels. Physical exam at admission shows pain while palpating the abdomen, more intense in left upper abdominal quadrant and left flank; bowel sounds were present and there were no vascular murmurs on the main arteries. The peripheral arterial pulses were normal. The clinical interpretation was suboclusive syndrome (Konig) possible due to postoperatory obstruction or adherential syndrome. Laboratory findings were: inflammatory syndrome, with elevated sedimentation rate and alpha 2 globulins (60/95 mm/h and 18% respectively), leucocytosis of 11500/mm 3, normal values for total cholesterol, plasma triglycerides and HDL-cholesterol. Upper gastrointestinal tract was investigated endoscopically, which revealed an axial hiatal hernia with stage II esophagitis. Small-bowel enema (enteroclysis) revealed a 20 centimeter segment of small intestine which remained un-distained by the contrast substance and was probably secondary to a chronic, stenotic process. (Fig. 1) Figure 1. Radioscopy-guided barium enema. It is obvious the narrowed bowel segment during the exam (arrow). On Doppler ultrasound examination the inferior mesenteric artery was found to be completely obstructed, while the superior mesenteric artery was only partially obstructed in the proximal part, the thrombosis being of 75% of the lumen. On the fourth day of admittance the patient developed an acute ischemic occlusion of right popliteal artery; Doppler ultrasound revealed a complete occlusion by an acute thrombosis of the popliteal artery with extension of the thrombus in the anterior tibial artery, but without any significant signs of atherosclerotic injury. (Fig. 2) Figure 2. Doppler ultrasound of popliteal region, transversal section. Popliteal artery (AP) fully occluded without color Doppler signal. VP - popliteal vena. Anticoagulants and vasodilators rapidly and significantly improved the symptomatology, without the need an invasive desobstruating intervention. Abdominal arteries arteriography (Fig. 3,4) and of the lower limbs arteries performed only two weeks after the event (due to technical reasons), confirmed the occlusion of the popliteal artery (Fig. 5) and the inferior mesenteric artery, without significant proof of atherosclerotic lesions (plaques), while the superior mesenteric artery was permeable. Three days after arteriography the patient developed another episode of mesenteric infarction, although under anticoagulant therapy. This time, 70 centimeters of necrotic jejunum was resected. Post surgical evolution was unfavorable, so the next day a new surgical intervention was necessary, and this time 45 centimeters of necrotic jejunum was resected, at a distance from the previous intervention. Intraoperatory the thromboses of the small mesenteric arteries was established; no lesions at the inspection of the colon were found. The histopathological exam excluded the vasculitis aspects on the resected segment, showing only the thrombosis of the small mesenteric arteries. (Fig. 6) All the common coagulation tests performed were normal (platelets count, Quick time, partial activated thromboplastine time, antithrombin III, antiphospholipid antibodies); so we had to go further with the investigation for the coagulating and the fibrinolitic processes. Factor V resistance to activated protein C, factor VIII activity, plasma folic 44 TMJ 2007, Vol. 57, No. 1
3 Figure 3. Abdominal angiography. Inferior mesenteric artery is complete thrombosed. There are no atherosclerotic injuries and all the other abdominal vessel are normal. Figure 6. Histopathology from the latest intestinal infarction. Small vessels are thrombosed. The final diagnosis was: Type II protein S deficiency. Hyperhomocysteinemia. Wild type MTHFR C677T genotype. The patient continued with the anticoagulation therapy: first heparin, followed by warfarin, in association with aspirin, folate and vitamin B6 and B12 supplements. Further determination of homocysteine levels was not possible, but clinical evolution was good, without any thrombotic events in the next two years of surveillance. Figure 4. Normal aspect of bilateral iliac arteries on angiography. Figure 5. Right leg angiography. Complete occlusion of right popliteal artery (arrow), without collateral vessels (acute occlusion). acid and plasma vitamin B12 level were all in normal ranges. The study of prothrombin gene variant and of MTHFR (methylenetetrahydrofolate reductase) C677T gene polymorphism showed the presence of wild type. Plasma homocysteine level was elevated µmol/l (risk limit under 12.5 µmol/l), protein S activity was 44% (normal values between 65 and 140%), with normal free protein S antigen level. Discussions The term of thrombophilia or prothrombotic status refers to the cases where acquired or inherited coagulation disorders enhance the susceptibility of developing venous and/or arterial thromboses. 1,2 Multiple factors causing thrombophilia can determine thrombosis in both arterial and venous territory, but according to the etiological factor there is a predominance of either of them. 2-4 (Table 1) Facing an arterial and/or venous thrombotic disorder, the aquired risk factors are the first and the easiest to analyze and identify. In a recurrent thrombotic disorder or when there are other features of thrombotic predisposition (young age and/or unusual sites of thrombosis), further investigation of the coagulation process is needed. Recurrent arterial thrombosis in our patient, at a young age (48 years old), without any signs of atherosclerosis on vascular Doppler ultrasound and angiography, leads to a complete investigation of all inherited and acquired risk factors to explain these episodes. As hyperhomocysteinemia is frequently reported in association with thrombotic events, that was the first risk factor we looked for. 2,5-7 Homocysteine Daniela Fodor et al 45
4 Table 1. Acquired and inherited factors associated with arterial and venous thrombosis. Acquired factors Inherited disorders Arterial thrombosis Atherosclerosis Diabetes mellitus Tobacco smoking Oral contraceptives Polycythemia Thrombocytosis Paroxysmal nocturnal hemoglobinuria Sickle cell anemia Heparin induced thrombocytosis Antiphospholipid syndrome Hyperhomocysteimemia High Lp(a) Prothrombin G20210A mutation Protein S deficiency Venous thrombosis Prolonged immobilization Trauma Surgery Pregnancy, postpartum Oral contraceptives Neoplasia Cancer chemotherapy Antiphospholipid syndrome Antithrombin, protein C, protein S deficiency Factor V resistance to activated protein C Prothrombin G20210A mutation Plasminogen deficiency, t-pa decrease or PAI-1 increase APC-activated protein C; PAI-1 - plasminogen activator inhibitor 1; t-pa tissue plasminogen activator; Lp(a) lipoprotein a. is a sulfur-containing amino acid formed during the metabolism of methionine. Metabolism of homocysteine occurs along two major enzymatic pathways, either remethylation or transsulfuration, which require folate and vitamine B12 or vitamine B6 respectively. 8,9 High plasma homocysteine levels occur in mutations in one of the enzymes involved in homocysteine metabolism. In homozygous patients the elevation is important (over 50 µmol/l) with high risk for myocardic infarction and high morbidity and mortality associated with thromboembolism, stroke, and arterial peripheral thrombosis. Also, increased plasma homocysteine levels may occur if there is not an adequate supply of vitamin B12, folate, or in chronic renal failure cases. These cases are more frequent in adults and produce only mild increases in homocysteine levels. Despite the etiology of the mild or moderate hyperhomocysteinemia (genetic mutation with homozygous or heterozygous forms or nutritional defects), this increase is considered to be an independent risk factor for stoke, ischemic heart disease and peripheral artery disease. 8 Chanarin (cited by ref. 8) showed that for every increase with 5 µmol/l of homocystein levels the relative risk for coronary heart disease increases with 40%. The prospective studies of recurrent cardiovascular events showed that the hazard ratio for a recurrent event increases by 16% with each increase of 5 µmol/l in the serum homocysteine concentration. 10 Also, lowering homocysteine concentrations with folate supplements by 3 µmol/l from current levels reduces the risk of ischemic heart disease by 16%, of deep vein thrombosis by 25%, and of stroke by 24%. 10 There is evidence in vitro and in vivo that homocysteine is an atherogenic determinant that promotes oxidative stress, inflammation, thrombosis, endothelial dysfunction, and cell proliferation. 11 In fact, the effects of elevated homocysteine levels appear to affect both vascular wall structure, and blood coagulation system. Due to the moderate elevation of the homocysteine level and the absence of the atherosclerotic lesions on Doppler and angiographic examination, in our case we considered an associated risk factor explaining the amount and the extent of the thrombotic lesions. A second risk factor which could have explained the thrombotic predisposition in this patient with mild hyperhomocysteinemia was identified as type II protein S deficiency (inherited, so pre-existent to hyperhomocysteinemia). Protein S it is a vitamin K dependent glycoprotein which acts as a cofactor for protein C to inactivate factors Va and VIIIa. In plasma, protein S has two circulating forms: 60% as a covalent complex with β-chain of the complement component C4b binding protein, while the remaining 40% is free. There are three types of protein deficiency: type I characterized by low total and free protein S antigen level; type II characterized by normal free protein S level, but reduced activated protein C cofactor activity and type III, by a selective reduction in free protein S levels. 11,12 Protein S deficiency is a well known risk factor for venous thrombosis, with a 2.4 higher risk for such events including less common sites, like mesenteric or cerebral veins. 13,14 Occasionally, arterial thrombosis can be found. In our case, Doppler ultrasound revealed thrombosis of the superior mesenteric artery which 46 TMJ 2007, Vol. 57, No. 1
5 was not confirmed on arteriography. This could be explained by the lysis of the thrombus after the heparin therapy was initiated, while angiography was performed 2 weeks later. Even though the anticoagulant therapy was administered in proper dosage, it was not efficient on the small branches of superior mesenteric artery as the two successive intestinal infarctions followed. This comes as an argument for the multiple mechanisms involved in thrombus formation in our patient. It is also of interest that the colon was normal on macroscopic examination during surgery, in spite of the fact that the branches of the superior mesenteric artery and further more, the main branch of the inferior mesenteric artery were occluded. The occlusion of inferior mesenteric artery could have been a gradual one, so the collateral vessels could have formed and supplied the involved territory. The involvement of hyperhomocysteinemia as a risk factor for thrombosis in this patient is obvious from the response to the treatment. Two intestinal infarctions had occurred while treated with heparin; but when given vitamin supplements (vitamin B6 and vitamin B12) and folate there were no recurrences during the two year period in which we followed her. Unfortunately it was not possible to repeat the measurement of the homocysteine levels during the vitamin treatment but, based on clinical evolution, we can only assume that the levels returned to normal values. Even though recent studies are questioning the importance of routine measurement of plasma levels of homocysteine and that of treatment with vitamin supplements and folate in order to prevent atherothrombotic diseases, these measures proved to be beneficial in our case. 15 This case is of great interest due to the association between two factors: one of them inherited (protein S deficiency) and the other one acquired (mild hyperhomocysteinemia). The pro-thrombotic activity of the first factor became clinically evident in the presence of the second one. It is possible that if any of the two risk factors were independent, they couldn t have generated such a significant thrombotic process. REFERENCES 1. Girolami A, Simioni P, Scarano L, et al. Venous and arterial trombophilia. Hematologica 1997;82: De Stefano V, Rossi E, Paciaroini K, et al. Screening for inherited trombophilia: indicatins and therapeutic implications. Hematologica 2002;87: League S, Hooper WC. Molecular diagnostics of inheriteed thrombosis. Clin Lab Sci 2005;18(5): Makin A, Silverman SH, Lip GYH. Peripheral vascular disease and Virchow s triad for thrombogenesis. O J Med 2002;95: Bohm G, Al-Khaffaf H. Trombophilia and arterial disease. An up-todate review of the literature for the vascular surgeon. Int Angiol 2003;22(2): D Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood, 1997;90: Stein JM, McBride PE. Hyperhomocysteinemia and atheroclerotic vascular disease: pathophysiology, screening, and treatment. Arch Intern Med 1998;158: Carmel R, Green R, Rosenblatt DS, et al. Update on cobalamine, folate and homocysteine. Hematology Am Soc Hematol Educ Program. 2003:334: Welch GN, Loscalzo J. Mechanisms of Disease: Homocysteine and atherothrombosis. N Engl J Med 1998;338: Wald D, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325: Loscalzo J. Homocysteine trials-clear outcomes for complex reasons. N Engl J Med 2006; 354: Markris M, Leach M, Beauchamp NJ, et al. Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood 2000;95: Simmonds RE, Zőller B, Ireland H, et al. Genetic and phenotypic analysis of a large (122 members) protein S-deficient kindred provides an explanation for the familial coexistence of type I and type II plasma phenotypes. Blood. 1997;89: Faioni EM, Valsecchi C, Palla A, et al. Free protein S deficiency is a risk factor for venous thrombosis. Thromb Haemost. 1997;78: Kaul S, Zadeh AA, Prediman K, et al Homocysteine hypothesis for atherothrombotic cardiovascular disease not validated. J Am Coll Cardiol, 2006;48: Daniela Fodor et al 47
Thrombophilia. Diagnosis and Management. Kevin P. Hubbard, DO, FACOI
Thrombophilia Diagnosis and Management Kevin P. Hubbard, DO, FACOI Clinical Professor of Medicine Kansas City University of Medicine and Biosciences-College of Osteopathic Medicine Kansas City, Missouri
More informationThrombosis. By Dr. Sara Mohamed Abuelgasim
Thrombosis By Dr. Sara Mohamed Abuelgasim 1 Thrombosis Unchecked, blood coagulation would lead to dangerous occlusion of blood vessels if the protective mechanisms of coagulation factor inhibitors, blood
More informationVENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK?
VENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK? Ayman El-Menyar (1), MD, Hassan Al-Thani (2),MD (1)Clinical Research Consultant, (2) Head of Vascular Surgery, Hamad General Hospital
More informationApproach to Thrombosis
Approach to Thrombosis Theera Ruchutrakool, M.D. Division of Hematology Department of Medicine Siriraj Hospital Faculty of Medicine Mahidol University Approach to Thrombosis Thrombosis: thrombus formation
More informationAre there still any valid indications for thrombophilia screening in DVT?
Carotid artery stenosis and risk of stroke Are there still any valid indications for thrombophilia screening in DVT? Armando Mansilha MD, PhD, FEBVS Faculty of Medicine of University of Porto Munich, 2016
More informationMabel Labrada, MD Miami VA Medical Center
Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and
More informationThrombophilia due to Activated Protein C Resistance
CASE REPORT JIACM 2005; 6(3): 244-7 Thrombophilia due to Activated Protein C Resistance Kamal S Saini*, Mrinal M Patnaik*, Vidya S Nagar**, Alaka K Deshpande*** Abstract Thrombophilia is a hereditary or
More informationLaboratory Evaluation of Venous Thrombosis Risk
Laboratory Evaluation of Venous Thrombosis Risk Dorothy M. Adcock, MD Volume 17, Number 12 December 2003 Objective: The reader will be able to discuss the concepts of risk factor, risk potential and thrombotic
More informationThursday, February 26, :00 am. Regulation of Coagulation/Disseminated Intravascular Coagulation HEMOSTASIS/THROMBOSIS III
REGULATION OF COAGULATION Introduction HEMOSTASIS/THROMBOSIS III Regulation of Coagulation/Disseminated Coagulation necessary for maintenance of vascular integrity Enough fibrinogen to clot all vessels
More informationLearning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship
Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship CLINICAL PROBLEMS IN VASCULAR SURGERY 1. ABDOMINAL AORTIC ANEURYSM A 70 year old man presents in the emergency department with
More informationTHROMBOPHILIA SCREENING
THROMBOPHILIA SCREENING Introduction The regulation of haemostasis Normally, when a clot occurs, it exactly occurs where it has to be and does not grow more than necessary due to the action of the haemostasis
More informationHemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D.
Hemodynamic Disorders, Thrombosis, and Shock Richard A. McPherson, M.D. Edema The accumulation of abnormal amounts of fluid in intercellular spaces of body cavities. Inflammation and release of mediators
More informationPotpourri of Hematology Oncology. Jasmine Nabi, M.D. Oncology Associates Hall-Perrine Cancer Center at Mercy
Potpourri of Hematology Oncology Jasmine Nabi, M.D. Oncology Associates Hall-Perrine Cancer Center at Mercy Lifestyle Modifications to Decrease the Risk of Colorectal Cancer Estimates for 2018 American
More informationAssociation between Plasma Homocysteine Concentrations and Carotid Intima-Media Thickness in Patients with Coronary Artery Disease
Association between Plasma Homocysteine Concentrations and Carotid Intima-Media Thickness in Patients with Coronary Artery Disease ROXANA BUZAŞ, CORINA ŞERBAN, IOANA SUCEAVA, DANIEL LIGHEZAN University
More informationSinus and Cerebral Vein Thrombosis
Sinus and Cerebral Vein Thrombosis A Summary Sinus and cerebral vein clots are uncommon. They can lead to severe headaches, confusion, and stroke-like symptoms. They may lead to bleeding into the surrounding
More informationCLINICAL CASE PRESENTATION
European Winter School of Internal Medicine 2015 Riga, Latvia, 26-30 January CLINICAL CASE PRESENTATION Vasiliy Chulkov South Ural State Medical University (Chelyabinsk, Russia) CHELYABINSK CLINICAL HISTORY
More informationJordan M. Garrison, MD FACS, FASMBS
Jordan M. Garrison, MD FACS, FASMBS Peripheral Arterial Disease (PAD) Near or Complete obstruction of > 1 Peripheral Artery Peripheral Venous reflux Disease Varicose Veins Chronic Venous Stasis Ulcer Disease
More informationTHROMBOPHILIA TESTING: PROS AND CONS SHANNON CARPENTER, MD MS CHILDREN S MERCY HOSPITAL KANSAS CITY, MO
THROMBOPHILIA TESTING: PROS AND CONS SHANNON CARPENTER, MD MS CHILDREN S MERCY HOSPITAL KANSAS CITY, MO DISCLAIMER I m a pediatrician I will be discussing this issue primarily from a pediatric perspective
More informationWhat are blood clots?
What are blood clots? Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service GP Partner Westcliffe Medical Group Created 5/31/18 Dr. Matthew
More informationLipid Markers. Independent Risk Factors. Insulin Resistance Score by Lipid Fractionation
Patient: SAMPLE PATIENT DOB: Sex: MRN: 3701 CV Health Plus Genomics - Plasma, Serum & Buccal Swab Methodology: Chemiluminescent, Enzymatic, Immunoturbidimetric, NMR and PCR Lipid Markers Cholesterol LDL-
More informationScott M. Stevens, MD. Co-Director, Thrombosis Clinic. Associate Professor of Clinical Medicine
Scott M. Stevens, MD Co-Director, Thrombosis Clinic Intermountain Medical Center Associate Professor of Clinical Medicine The University of Utah School of Medicine No Relevant Financial Relationships Research
More informationHyperhomocysteinemia, Deep Vein Thrombosis and Vitamin B12 Deficiency in a Metformin-treated Diabetic Patient
CASE REPORT Hyperhomocysteinemia, Deep Vein Thrombosis and Vitamin B12 Deficiency in a Metformin-treated Diabetic Patient Hsuan-Yu Lin, 1 Chih-Yuan Chung, 1 Cheng-Shyong Chang, 1 Ming-Lun Wang, 1 Jen-Shiou
More informationATHEROSCLEROSIS. Secondary changes are found in other coats of the vessel wall.
ATHEROSCLEROSIS Atherosclerosis Atherosclerosis is a disease process affecting the intima of the aorta and large and medium arteries, taking the form of focal thickening or plaques of fibrous tissue and
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/19768 holds various files of this Leiden University dissertation. Author: Langevelde, Kirsten van Title: Are pulmonary embolism and deep-vein thrombosis
More informationEpidemiologia e clinica del tromboembolismo venoso. Maria Ciccone Sezione di Ematologia e Fisiopatologia della Coagulazione
Epidemiologia e clinica del tromboembolismo venoso Maria Ciccone Sezione di Ematologia e Fisiopatologia della Coagulazione Thrombophilia may present clinically as one or more of several thrombotic manifestations
More informationJOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH How to cite this article: CHOWTA NITHYANANDA K, ARUN S, BIPIN P, FAZIL A. CHRONIC THROMBOEMBOLIC PULMONARY ARTERY HYPERTENSION WITH DEEP VEIN THROMBOSIS DUE
More informationThe Multi-Factorial Threshold Model of Thrombotic Risk
The Multi-Factorial Threshold Model of Thrombotic Risk Richard A. Marlar, PhD and Dorothy M. Adcock, MD The incidence of venous thrombosis in the US is between two and three million per year, resulting
More informationDISCLOSURE. Presented by: Merav Sendowski, MD Oregon Health and Science University
Thrombophilia! DISCLOSURE Presented by: Merav Sendowski, MD Oregon Health and Science University Created by: Thomas Deloughery, MD Oregon Health and Science University Current Relevant Financial Relationship(s)
More informationPathology of pulmonary vascular disease. Dr.Ashraf Abdelfatah Deyab. Assistant Professor of Pathology Faculty of Medicine Almajma ah University
Pathology of pulmonary vascular disease Dr.Ashraf Abdelfatah Deyab Assistant Professor of Pathology Faculty of Medicine Almajma ah University Pulmonary vascular disease Type of pulmonary circulation: Types
More informationThrombophilia. Stephan Moll, MD Medicine, Heme-Coag UNC Chapel Hill, NC. GASCO Atlanta Sept 8 th, Disclosures. Conflicts of interest: NONE
LA APLA 1 3 ACA Anti-ß2-GP I 2 45 Thrombophilia Stephan Moll, MD Medicine, Heme-Coag UNC Chapel Hill, NC GASCO Atlanta Sept 8 th, 2017 Disclosures Conflicts of interest: NONE Off-label product use discussion:
More informationMolecular mechanisms & clinical consequences. of prothrombin mutations. A.J. Hauer
Molecular mechanisms & clinical consequences of prothrombin mutations A.J. Hauer 07-12-2018 Prothrombin & the coagulation cascade Coagulation factor II, thrombin. Prothrombin is synthesized in the liver
More informationSWISS SOCIETY OF NEONATOLOGY. Neonatal cerebral infarction
SWISS SOCIETY OF NEONATOLOGY Neonatal cerebral infarction May 2002 2 Mann C, Neonatal and Pediatric Intensive Care Unit, Landeskrankenhaus und Akademisches Lehrkrankenhaus Feldkirch, Austria Swiss Society
More informationThrombophilia. Dr. A Sarrafnejad PhD Dep. Immunology School of public health TUMS
Autoimmune Thrombophilia Dr. A Sarrafnejad PhD Dep. Immunology School of public health TUMS Saraf@sina.tums.ac.ir Acquired Thrombophilia HIT PNH Cyckle cell Anemia Myeloproliferative lf Diseases Thrombocytosis
More informationArterial Ischemic Stroke with Protein S Deficiency in Pakistan
Case Reports Arterial Ischemic Stroke with Protein S Deficiency in Pakistan Faika Usman, Ali Hassan, Arsalan Ahmad From Section of Neurology, Department of Medicine, Shifa International Hospitals and College
More informationVTE in Children: Practical Issues
VTE in Children: Practical Issues Wasil Jastaniah MBBS,FAAP,FRCPC Consultant Pediatric Hem/Onc/BMT May 2012 Top 10 Reasons Why Pediatric VTE is Different 1. Social, ethical, and legal implications. 2.
More informationDOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS
TOKUDA HOSPITAL SOFIA DOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS MILENA STANEVA, MD, PhD Department of vascular surgery and angiology Venous thromboembolic disease continues to cause significant morbidity
More informationPUT YOUR BEST FOOT FORWARD
PUT YOUR BEST FOOT FORWARD Bala Ramanan, MBBS 1 st year vascular surgery fellow Introduction The epidemic of diabetes and ageing of our population ensures critical limb ischemia will continue to grow.
More informationHow long to continue anticoagulation after DVT?
How long to continue anticoagulation after DVT? Dr. Nihar Ranjan Pradhan M.S., DNB (Vascular Surgery), FVES(UK) Consultant Vascular Surgeon Apollo Hospital, Jubilee Hills, Hyderabad (Formerly Faculty in
More informationInherited Thrombophilia Testing. George Rodgers, MD, PhD Kristi Smock MD
Inherited Thrombophilia Testing George Rodgers, MD, PhD Kristi Smock MD Prevalence and risk associated with inherited thrombotic disorders Inherited Risk Factor % General Population % Patients w/ Thrombosis
More informationVenous thromboembolism (VTE) consists of deep vein
Clinical Utility of Factor V Leiden (R506Q) Testing for the Diagnosis and Management of Thromboembolic Disorders Richard D. Press, MD, PhD; Kenneth A. Bauer, MD; Jody L. Kujovich, MD; John A. Heit, MD
More informationWhat is the real place of venous echo Doppler in aircrew member flying rehabilitation after a thromboembolism event?
89 th ASMA ANNUAL SCIENTIFIC MEETING DALLAS- May 6-10, 2018 What is the real place of venous echo Doppler in aircrew member flying rehabilitation after a thromboembolism event? S BISCONTE (1), V MARICOURT
More informationبسم الله الرحمن الرحيم أوتيتم من العلم إال قليال وما
بسم الله الرحمن الرحيم أوتيتم من العلم إال قليال وما 1 2 Goals of the Lecture: What is the portal vein? How common is PVT? What conditions are associated with PVT? How does patient with PVT present? How
More informationCardioGenomicPlus Profile
CardioGenomicPlus Profile Patient: SAMPLE PATIENT DOB: Sex: MRN: Apo E Chromosome 19 APOE APO E2: cys / cys APO E3: cys / arg APO E4: arg / arg The two SNPs lead to 3 possible variants for each chromosome,
More informationGeneral Data. 王 X 村 78 y/o 男性
General Data 王 X 村 78 y/o 男性 Chief Complaint Vomiting twice this early morning Fever up to 38.9ºC was noted Present Illness (1) Old CVA with left side weakness for more than 10 years and with bed ridden
More informationDVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center
DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients David Liff MD Oklahoma Heart Institute Vascular Center Overview Pathophysiology of DVT Epidemiology and risk factors for DVT in the
More informationGenetic Tests for the Better Outcome of VTE? 서울대학교병원혈액종양내과윤성수
Genetic Tests for the Better Outcome of VTE? 서울대학교병원혈액종양내과윤성수 Thrombophilia A hereditary or acquired disorder predisposing to thrombosis Questions Why should we test? Who should we test For what disorders?
More informationHandbook for Venous Thromboembolism
Handbook for Venous Thromboembolism Gregory Piazza Benjamin Hohlfelder Samuel Z. Goldhaber Handbook for Venous Thromboembolism Gregory Piazza Cardiovascular Division Harvard Medical School Brigham and
More informationWhat s New in DVT & PE
What s New in DVT & PE Mark Buch MD CM CCFP(EM) Attending physician Emergency Department Jewish General Hospital Family Physician and Medical Director GMF Santé Mont-Royal Objectives: Review the diagnostic
More informationCOAGULATION INHIBITORS LABORATORY DIAGNOSIS OF PROTHROMBOTIC STATES REGULATION OF. ANTICOAGULANT PROTEIN DEFICIENCY Disease entities COAGULATION
LABORATORY DIAGNOSIS OF PROTHROMBOTIC COAGULATION INHIBITORS Tissue Factor Pathway Inhibitor (TFPI) Lipoprotein Associated Coagulation Inhibitor (LACI) Extrinsic Pathway Inhibitor (EPI) Complexes with
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/19768 holds various files of this Leiden University dissertation. Author: Langevelde, Kirsten van Title: Are pulmonary embolism and deep-vein thrombosis
More informationDiagnosis of hypercoagulability is by. Molecular markers
Agenda limitations of clinical laboratories to evaluate hypercoagulability and the underlying cause for thrombosis what is the INR the lupus anticoagulant and the antiphospholipid antibody syndrome hassouna
More informationTHROMBOSIS. Dr. Nisreen Abu Shahin Assistant Professor of Pathology Pathology Department University of Jordan
THROMBOSIS Dr. Nisreen Abu Shahin Assistant Professor of Pathology Pathology Department University of Jordan NORMAL BLOOD VESSEL HISTOLOGY THROMBOSIS Pathogenesis (called Virchow's triad): 1. Endothelial*
More informationThrombosis and emboli. Peter Nagy
Thrombosis and emboli Peter Nagy A thrombus is any solid object developing from the blood in vivo within the vascular system or heart. Thrombosis is hemostasis in the wrong place. Major components, forms:
More informationClinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden
Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Number: 05.01.03 Effective Date: January 1, 2016 Initial Review Date: July 15, 2015 Most Recent Review Date:
More informationSindrome da anticorpi antifosfolipidi: clinica e terapia. Vittorio Pengo Clinical Cardiology, Padova, Italy
Sindrome da anticorpi antifosfolipidi: clinica e terapia Vittorio Pengo Clinical Cardiology, Padova, Italy Revised Classification Criteria for the Antiphospholipid Syndrome J Thromb Haemost 2006;4:295-306
More informationPathophysiology. Tutorial 3 Hemodynamic Disorders
Pathophysiology Tutorial 3 Hemodynamic Disorders ILOs Recall different causes of thrombosis. Explain different types of embolism and their predisposing factors. Differentiate between hemorrhage types.
More informationIntended Learning Outcomes
2011 Acute Limb Ischemia Definition, Etiology & Pathophysiology Clinical Evaluation Management Ali SABBOUR Prof. of Vascular Surgery, Ain Shams University Acute Limb Ischemia Intended Learning Outcomes
More informationG20210A prothrombin gene mutation identified in patients with venous leg ulcers
J.Cell.Mol.Med. Vol 5, No 4, 2001 pp. 397-401 G20210A prothrombin gene mutation identified in patients with venous leg ulcers Gh. Jebeleanu, Lucia Procopciuc * Department of Medical Biochemistry, University
More informationDave Duddleston, MD VP and Medical Director Southern Farm Bureau Life
Dave Duddleston, MD VP and Medical Director Southern Farm Bureau Life Sources of Risk for Venous Diseases Pulmonary embolism (thrombus) Bleeding from anticoagulation Mortality from underlying disease Chronic
More informationGenetics of Arterial and Venous Thrombosis: Clinical Aspects and a Look to the Future
Genetics of Arterial and Venous Thrombosis: Clinical Aspects and a Look to the Future Paul M Ridker, MD Eugene Braunwald Professor of Medicine Harvard Medical School Director, Center for Cardiovascular
More informationVENOUS THROMBOEMBOLISM: DURATION OF TREATMENT
VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT OBJECTIVE: To provide guidance on the recommended duration of anticoagulant therapy for venous thromboembolism (VTE). BACKGROUND: Recurrent episodes of VTE
More informationAnnals of RSCB Vol. XVI, Issue 1
THE STUDY OF PROTHROBOTIC STATE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR DISEASES Oana Bădulescu 1, Codruţa Bădescu 2, Manuela Ciocoiu 1, Magda Bădescu 1 1 DEPARTMENT OF PATHOPHYSIOLOGY;
More informationVascular Ultrasound: Current state, current needs, future directions
Vascular Ultrasound: Current state, current needs, future directions Laurence Needleman, MD Thomas Jefferson University Hospitals Sidney Kimmel Medical College of Thomas Jefferson University Disclosures
More informationVenous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community
Venous Thrombosis Venous Thrombosis It occurs mainly in the deep veins of the leg (deep vein thrombosis, DVT), from which parts of the clot frequently embolize to the lungs (pulmonary embolism, PE). Fewer
More information2017/04/21 R1 歐宗頴. Case Discussion
2017/04/21 R1 歐宗頴 Case Discussion Case Demography Name: 18143xxx Age: 14y/o Gender: boy Admission: 2017/04/07 Chief complaint: recurrent fever with RUQ pain for 6 weeks Past History G3P3 full term NSD
More informationFaculty Disclosure. Hypercoagulable States. Learning Objectives. Hereditary Thombophilia. Acquired Hypercoagulable States 5/9/2016
Faculty Disclosure Hypercoagulable States Dr. Rizal has no actual or potential conflict of interest associated with this presentation By: Dr. Anuja Rizal Pharm. D., RPh., CACP Clinical Coordinator UConn
More informationA study of clinical profile of 50 patients deep venous thrombosis at general hospital
Research Article A study of clinical profile of 50 patients with deep venous thrombosis at general hospital Kasabe P S 1, Jaykar R D 2, Lakhpatre S B 3* 1 Assistant professor, 2 Associate professor, 3
More informationHypercoagulable State
1 1 4 Hypercoagulable State Andrew I. Schafer The Concept of Hypercoagulability................ 2423 Primary Hypercoagulable States.................. 2426 Secondary Hypercoagulable States................
More informationCLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION
Donald L. Renfrew, MD Radiology Associates of the Fox Valley, 333 N. Commercial Street, Suite 100, Neenah, WI 54956 6/23/2012 Radiology Quiz of the Week # 78 Page 1 CLINICAL PRESENTATION AND RADIOLOGY
More informationOUTPATIENT DEPARTMENT
1 This chapter outlines the main arterial and venous diseases that are likely to be seen within a vascular outpatient setting. It also highlights the role of the vascular nurse specialist wherever appropriate.
More informationOPEN ACCESS TEXTBOOK OF GENERAL SURGERY
OPEN ACCESS TEXTBOOK OF GENERAL SURGERY MESENTERIC ISCHAEMIA P Zwanepoel INTRODUCTION Mesenteric ischaemia results from hypoperfusion of the gut, most commonly due to occlusion, thrombosis or vasospasm.
More informationDiagnosis and management of heritable thrombophilias
Link to this article online for CPD/CME credits Diagnosis and management of heritable thrombophilias Peter MacCallum, 1 2 Louise Bowles, 2 David Keeling 3 1 Wolfson Institute of Preventive Medicine, Barts
More informationHematologic Disorders. Assistant professor of anesthesia
Preoperative Evaluation Hematologic Disorders Dr M.Razavi Assistant professor of anesthesia Anemia Evaluation needs to consider the extent and type of surgery, the anticipated blood loss, and the patient's
More informationChapter. Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy
Chapter Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy Willem M. Lijfering Min Ki ten Kate Herman G. Sprenger Jan van der Meer
More informationIschemic heart disease
Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery
More informationChapter 1 Introduction
Chapter 1 Introduction There are several disorders which carry an increased risk of thrombosis, clots that interfere with normal circulation, including: venous thromboembolism (VTE), comprising both deep
More informationDeep Vein Thrombosis and Pulmonary Embolism: Patient Information
Deep Vein Thrombosis and Pulmonary Embolism: Patient Information A Deep Vein Thrombosis (DVT) and a Pulmonary Embolism (PE) are both disorders of unwanted blood clotting. Unwanted blood clots can occur
More informationKey words: antiphospholipid syndrome, trombosis, pathogenesis
26. XI,. 4/2011,.,..,..,., -..,,. 2GPI. -,.,,., -,, -, -,,,,, IL-1, IL-2, IL-6, IL-8, IL-12, IL-10, TNF, INF-. :,, N. Stoilov, R. Rashkov and R. Stoilov. ANTIPHOSPHOLIPID SYNDROME HISTORICAL DATA, ETI-
More informationRECURRENT VENOUS THROMBOEMBOLISM AND MUTATION IN THE GENE FOR FACTOR V
THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH AN Arg 506 Gln MUTATION IN THE GENE FOR FACTOR V (FACTOR V LEIDEN) PAOLO SIMIONI, M.D., PAOLO PRANDONI, M.D., PH.D., ANTHONIE W.A. LENSING,
More informationAnnals of RSCB Vol. XVII, Issue 1/2012
CORRELATIONS BETWEEN ENDOTHELIAL DYSFUNCTION AND GLYCEMIA IN VENOUS THROMBOSIS PATHOGENESIS Codruţa Bădescu 1, Oana Bădulescu 2, Manuela Ciocoiu 2, Magda Bădescu 2, M. Costuleanu 2 1 DEPARTMENT OF INTERNAL
More informationThrombosis. Jeffrey Jhang, M.D.
Thrombosis Jeffrey Jhang, M.D. Introduction The human hemostatic system has evolved to maintain blood flow under normal physiologic conditions while remaining primed to rapidly respond to vascular injury
More informationCase 37 Clinical Presentation
Case 37 73 Clinical Presentation The patient is a 62-year-old woman with gastrointestinal (GI) bleeding. 74 RadCases Interventional Radiology Imaging Findings () Image from a selective digital subtraction
More informationHOMOCYSTEINE METABOLISM
Annu. Rev. Nutr. 1999. 19:217 46 Copyright c 1999 by Annual Reviews. All rights reserved HOMOCYSTEINE METABOLISM J. Selhub Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston,
More informationPeripheral Arterial Disease. Westley Smith MD Vascular Fellow
Peripheral Arterial Disease Westley Smith MD Vascular Fellow Background (per 10,000) Goodney P, et al. Regional intensity of vascular care and lower extremity amputation rates. JVS. 2013; 6: 1471-1480.
More informationDEEP VENOUS THROMBOSIS AMONG CARRIERS OF FACTOR V LEIDEN AND THE G20210A PROTHROMBIN MUTATION
DEEP VENOUS THROMBOSIS AMONG CARRIERS OF FACTOR V LEIDEN AND THE G20210A PROTHROMBIN MUTATION THE RISK OF RECURRENT DEEP VENOUS THROMBOSIS AMONG HETEROZYGOUS CARRIERS OF BOTH FACTOR V LEIDEN AND THE G20210A
More informationStroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013
Stroke 101 Maine Cardiovascular Health Summit Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013 Stroke Statistics Definition of stroke Risk factors Warning signs Treatment
More informationThrombophilia: To test or not to test
Kenneth Bauer, MD Harvard Medical School, Boston, MA Professor of Medicine VA Boston Healthcare System Chief, Hematology Section Beth Israel Deaconess Medical Center, Boston, MA Director, Thrombosis Clinical
More informationAnticoagulation in Special populations. Ng Heng Joo Department of Haematology Singapore General Hospital
Anticoagulation in Special populations Ng Heng Joo Department of Haematology Singapore General Hospital roymatheson.com Objectives Safer anticoagulation for The elderly Chronic kidney disease Obese patients
More informationFACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS
New Horizons In Atherothrombosis Treatment 2012 순환기춘계학술대회 FACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS Division of Cardiology, Jeonbuk National University Medical School Jei Keon Chae,
More informationCLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION
Donald L. Renfrew, MD Radiology Associates of the Fox Valley, 333 N. Commercial Street, Suite 100, Neenah, WI 54956 6/30/2012 Radiology Quiz of the Week # 79 Page 1 CLINICAL PRESENTATION AND RADIOLOGY
More informationRecurrent Venous Thrombo-Embolism in a Young Adult Female: Case Report with Review of Literature
Cronicon OPEN ACCESS CARDIOLOGY Case Report Recurrent Venous Thrombo-Embolism in a Young Adult Female: Case Report with Review of Literature Ehab M Esheiba 1 *, Ani Purushothaman 2 1 Departments of Cardiology,
More informationDisclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None
Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)
More informationLung diseases of Vascular Origin. By: Shefaa Qa qqa
Lung diseases of Vascular Origin By: Shefaa Qa qqa Pulmonary Hypertension Pulmonary hypertension is defined as a mean pulmonary artery pressure greater than or equal to 25 mm Hg at rest. Based on underlying
More informationConsultative Coagulation How to Effectively Answer Common Questions About Hemostasis Testing Session #5000
Consultative Coagulation How to Effectively Answer Common Questions About Hemostasis Testing Session #5000 Dorothy M. (Adcock) Funk, M.D. Karen A. Moser, M.D. Esoterix Coagulation September 20, 2013 Disclosures
More informationHEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM
REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,
More informationImaging abdominal vascular emergencies. V.Stoynova
Imaging abdominal vascular emergencies V.Stoynova Abdominal vessels V. Stoynova 2 Acute liver bleeding trauma anticoagulant therapy liver disease : HCC, adenoma, meta, FNH, Hemangioma Diagnosis :CT angiography
More informationInnovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS
Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis Prof. Ralf R.Kolvenbach MD,PhD,FEBVS Catheter-based thrombolysis Local administration of lytic agent Higher local
More informationAnti-Thrombotic Therapy Update 2017 Sophia-Antipolis (France), February European Heart House
Anti-Thrombotic Therapy Update 2017 Sophia-Antipolis (France), February 23-25 2017 European Heart House SESSION 1: PATHOPHYSIOLOGY AND METHODOLOGY Understanding Thrombosis in... February 23 2017 14:10-15:45
More informationOptimal Utilization of Thrombophilia Testing
Optimal Utilization of Thrombophilia Testing Rajiv K. Pruthi, MBBS Special Coagulation Laboratory & Comprehensive Hemophilia Center Division of Hematology/Internal Medicine Dept of Laboratory Medicine
More information